1. Academic Validation
  2. In vitro and in vivo anti-Vibrio vulnificus activity of psammaplin A, a natural marine compound

In vitro and in vivo anti-Vibrio vulnificus activity of psammaplin A, a natural marine compound

  • Mol Med Rep. 2016 Sep;14(3):2691-6. doi: 10.3892/mmr.2016.5522.
Byung Cheol Lee 1 Arim Lee 1 Jee Hyung Jung 2 Sang Ho Choi 3 Tae Sung Kim 1
Affiliations

Affiliations

  • 1 Department of Life Sciences, College of Life Sciences and Biotechnology, Korea University, Seoul 136‑701, Republic of Korea.
  • 2 Department of Pharmacy, Pusan National University, Geumjeong‑gu, Busan 609‑735, Republic of Korea.
  • 3 National Research Laboratory of Molecular Microbiology and Toxicology, Department of Agricultural Biotechnology, Seoul National University, Seoul 151‑921, Republic of Korea.
Abstract

Vibrio vulnificus is known to induce severely fulminant and fatal septicemia in susceptible hosts. In the present study, the antimicrobial activity of natural marine product-derived compounds against V. vulnificus, were investigated in vitro and in vivo. Twelve pure compounds were isolated from natural marine products and their inhibitory effects on V. vulnificus-induced cytotoxicity were determined in INT‑407 cells. Among the 12 pure compounds tested, treatment with psammaplin A significantly suppressed V. vulnificus‑induced cytotoxicity in INT‑407 cells. Notably, treatment with psammaplin A (5-50 µg) had improved survival rates compared with that in the untreated mice, when the mice were infected with V. vulnificus intraperitoneally. In addition, the Bacterial load of V. vulnificus in several tissues (spleen, liver and small intestine) was significantly lower in psammaplin A‑treated mice than in untreated mice. Furthermore, psammaplin A treatment significantly suppressed the growth of V. vulnificus. Taken together, these results indicate that psammaplin A may be a potential agent for the prevention and treatment of V. vulnificus infections.

Figures
Products